[端粒在获得的无形性贫血的克隆进化中的作用 - - 评论]
1Hematology and Oncology Department, Children's Hospital of Chongqing Medical University; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disease; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
Zhongguo shi yan xue ye xue za zhi
|June 27, 2024
概括
获得的无可塑性贫血患者具有较短的端粒面临更长的疾病,更高的复发风险,并增加了克隆进化. 端粒长度由各种因素调节,影响遗传稳定性和患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 获得性无塑性贫血 (AAA) 是一种罕见的骨髓衰竭疾病.
- 端粒长度是细胞衰老和基因组稳定性的关键决定因素.
- 在AAA患者的显著小组中观察到缩短的端粒,与疾病严重程度相关.
研究的目的:
- 审查端粒长度在获得的无塑性贫血的克隆进化中的作用.
- 在AAA中探索影响端粒长度调节的因素.
- 了解端粒缩短对疾病进展和预后的影响.
主要方法:
- 在获得的无塑性贫血中调查端粒长度的研究的文献综述.
- 分析影响端粒维持的因素,包括端粒酶活性和相关基因.
- 检查端粒长度,遗传不稳定性和克隆进化之间的关系.
主要成果:
- 大约三分之一的AAA患者表现出缩短的端粒长度.
- 较短的端粒与疾病持续时间的延长,复发率的增加和整体存活率的降低相关.
- 端粒缩短有助于遗传不稳定,增加了AAA中克隆进化的风险.
结论:
- 端粒长度是获得的无塑性贫血的一个显著的预后因素.
- 端粒维护通路的调节失调有助于AAA病原和进展.
- 准端粒生物学可能为AAA患者提供治疗途径.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
T Cell Activation and Clonal Selection
699
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
699
Replication in Eukaryotes
13.7K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.7K
Cells of the Adaptive Immune Response
979
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
979
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324


